#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4482712	B	Inhibition of N-terminal His-tagged human PC-TP expressed in Escherichia coli using NBD-PC and donor and acceptor small unilamellar vesicles by fluorescence quench assay	Homo sapiens	26		assay format	Patent Bioactivity Data
2.	ALA4482715	B	Inhibition of StarD10 (unknown origin) using NBD-PC and donor and acceptor small unilamellar vesicles by fluorescence quench assay	Homo sapiens	9		single protein format	Patent Bioactivity Data
3.	ALA4482716	B	Inhibition of StarD7 (unknown origin) using NBD-PC and donor and acceptor small unilamellar vesicles by fluorescence quench assay	Homo sapiens	2		single protein format	Patent Bioactivity Data
4.	ALA4482717	B	Inhibition of PC-TP in human hepatocytes assessed as enhancement of insulin signaling by measuring p-S6K T389 levels at 0.05 to 0.1 uM incubated for 60 mins by immunoblot analysis	Homo sapiens	2		cell-based format	Patent Bioactivity Data
5.	ALA4482718	B	Inhibition of PC-TP in human hepatocytes assessed as enhancement of insulin signaling by measuring p-AKT S473 levels at 0.05 to 0.1 uM incubated for 60 mins by immunoblot analysis	Homo sapiens	2		cell-based format	Patent Bioactivity Data
6.	ALA4482719	B	Inhibition of PC-TP in human hepatocytes assessed as enhancement of insulin signaling by measuring p-GSK-3beta S9 levels at 0.05 to 0.1 uM incubated for 60 mins by immunoblot analysis	Homo sapiens	2		cell-based format	Patent Bioactivity Data
7.	ALA4482720	B	Inhibition of PC-TP in human hepatocytes assessed as enhancement of insulin signaling by measuring p-AMPK-alpha T172 levels at 0.05 to 0.1 uM incubated for 60 mins by immunoblot analysis	Homo sapiens	2		cell-based format	Patent Bioactivity Data